Noninvasive detection of colorectal cancer by analysis of exhaled breath

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 19, 2014, Pages 4757-4763

  Wang, Changsong ^a,b   Ke, Chaofu ^b   Wang, Xiaoyang ^a   Chi, Chunjie ^a   Guo, Lei ^a   Luo, Suqi ^a   Guo, Zhigang ^a   Xu, Guowang ^c   Zhang, Fengmin ^b   Li, Enyou ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Biomarkers; Cancer diagnosis; Colorectal cancer; Solid phase microextraction; Volatile organic compounds

Indexed keywords

BIOMARKERS; DISEASES; PRINCIPAL COMPONENT ANALYSIS; VOLATILE ORGANIC COMPOUNDS;

CANCER DIAGNOSIS; CHROMATOGRAPHY/MASS SPECTROMETRY; COLORECTAL CANCER; COLORECTAL CANCERS (CRC); EXHALED BREATH ANALYSIS; NON-INVASIVE DETECTION; PARTIAL LEAST SQUARES DISCRIMINANT ANALYSES (PLSDA); SOLID-PHASE MICROEXTRACTION;

DIAGNOSIS;

VOLATILE ORGANIC COMPOUND;

BREATH ANALYSIS; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; SOLID PHASE MICROEXTRACTION;

BREATH TESTS; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; SOLID PHASE MICROEXTRACTION; VOLATILE ORGANIC COMPOUNDS;

EID: 84904503530     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7865-x     Document Type: Article

References (31)

1. Kim HJ, Yu MH, Kim H, Byun J, Lee C (2008) Non invasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 41:685-692
2. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220-241
3. Bingham S, Riboli E (2004) Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4:206-215
4. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343:1603-1607
5. Fletcher RH (1986) Carcinoembryonic antigen. Ann Intern Med 104:66-73
6. Kronborg O, Fenger C, Olsen J et al (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348:1467-1471
7. Winawer SJ, Zauber AG, Ho MN, Jørgensen OD, Søndergaard O, The National Polyp Study Workgroup (1993) Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329:1977-1981
8. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, Greenberg J, Maxfield RA, Rom WN (2003) Detection of lung cancer with volatile markers in the breath. Chest 123:2115-2123
9. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O'Neill HJ (1985) Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 31:1278-1282
10. Hietanen E, Bartsch H, Béréziat JC, Camus AM, McClinton S, Eremin O, Davidson L, Boyle P (1994) Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr 48:575-586
11. Altomare DF, Di Lena M, Porcelli F, Trizio L, Travaglio E, Tutino M, Dragonieri S, Memeo V, de Gennaro G (2013) Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg 100:144-150
12. Xu ZQ, Broza YY, Ionsecu R, Tisch U, Ding L, Liu H, Song Q, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD, Leja M, Haick H (2013) A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br J Cancer 108:941-950
13. Barash O, Peled N, Tisch U, Bunn PA Jr, Hirsch FR, Haick H (2012) Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine 8:580-589
14. Chen X, Xu F, Wang Y, Pan Y, Lu D, Wang P, Ying K, Chen E, Zhang W (2007) A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer 110:835-844
15. Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, Tisch U, Haick H (2010) Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 103:542-551
16. Birken T, Schubert J, Miekisch W, Nöldge-Schomburg G (2006) A novel visually CO2 controlled alveolar breath sampling technique. Technol Health Care 14:499-506
17. Miekisch W, Kischkel S, Sawacki A, Liebau T, Mieth M, Schubert JK (2008) Impact of sampling procedures on the results of breath analysis. J Breath Res 2:026007
18. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A (2009) Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 9:348
19. Lin HM, Edmunds SJ, Helsby NA, Ferguson LR, Rowan DD (2009) Non-targeted urinary metabolite profiling of a mouse model of Crohn's disease. J Proteome Res 8:2045-2057
20. Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, Sebedio JL (2009) Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 393:163-175
21. Katajamaa M, Oresic M (2007) Data processing for mass spectrometry-based metabolomics. J Chromatogr A 1158:318-328
22. Trygg J, Holmes E, Lundstedt T (2007) Chemometrics in metabonomics. J Proteome Res 6:469-479
23. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, Velzen EJJ, Duijnhoven JPM, Dorsten FA (2008) Assessment of PLSDA cross validation. Metabolomics 4:81-89
24. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: apractical and powerful approach to multiple testing. J R Stat Soc Ser 29:1165-1188
25. Storey JD (2003) The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 31:2013-2035
26. Miekisch W, Schubert JK, Noeldge-Schomburg GF (2004) Diagnostic potential of breath analysis - focus on volatile organic compounds. Clin Chim Act 347:25-39
27. Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP (2012) The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 5:992-1006
28. Li J, Peng Y, Duan Y (2012) Diagnosis of breast cancer based on breath analysis: an emerging method. Crit Rev Oncol Hematol 19:S1040-S8428
29. Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P, Wai J (2010) Volatile biomarkers in the breath of women with breast cancer. J Breath Res 4:026003, 30
30. Carpagnano GE, Palladino GP, Martinelli D, Lacedonia D, Orlando S, Foschino-Barbaro MP (2012) Exhaled matrix metalloproteinase-9 in lung cancer. Rejuvenation Res 15:359-365
31. Filipiak W, Sponring A, Mikoviny T, Ager C, Schubert J, Miekisch W, Amann A, Troppmair J (2008) Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer Cell Int 8:17